Pegavision Corporation (TPE:6491)
Taiwan · Delayed Price · Currency is TWD 281.50
+1.00 (0.36%)
At close: Dec 23, 2025
Pegavision Market Cap
Pegavision has a market cap or net worth of 21.96 billion as of December 23, 2025. Its market cap has decreased by -24.33% in one year.
Market Cap
21.96B
Enterprise Value
19.09B
Revenue
6.90B
Ranking
n/a
PE Ratio
13.81
Stock Price
281.50
Market Cap Chart
Since December 30, 2014, Pegavision's market cap has increased from 9.60B to 21.96B, an increase of 128.72%. That is a compound annual growth rate of 7.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 22, 2025 | 21.88B | -25.60% |
| Dec 31, 2024 | 29.41B | -4.92% |
| Dec 29, 2023 | 30.93B | 4.20% |
| Dec 30, 2022 | 29.68B | -0.70% |
| Dec 30, 2021 | 29.89B | 50.88% |
| Dec 31, 2020 | 19.81B | 55.92% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 252.02B |
| PharmaEssentia | 183.81B |
| Heron Neutron Medical | 82.63B |
| Lotus Pharmaceutical | 75.08B |
| Bora Pharmaceuticals Co., LTD. | 62.46B |
| Lin BioScience | 33.05B |
| Lumosa Therapeutics | 32.01B |
| Oneness Biotech | 28.18B |